955 related articles for article (PubMed ID: 28643028)
1. Polycystic ovary syndrome, adipose tissue and metabolic syndrome.
Delitala AP; Capobianco G; Delitala G; Cherchi PL; Dessole S
Arch Gynecol Obstet; 2017 Sep; 296(3):405-419. PubMed ID: 28643028
[TBL] [Abstract][Full Text] [Related]
2. Adipose tissue dysfunction, adipokines, and low-grade chronic inflammation in polycystic ovary syndrome.
Spritzer PM; Lecke SB; Satler F; Morsch DM
Reproduction; 2015 May; 149(5):R219-27. PubMed ID: 25628442
[TBL] [Abstract][Full Text] [Related]
3. The role of insulin and selected adipocytokines in patients with polycystic ovary syndrome (PCOS) - a literature review.
Ozegowska KE; Pawelczyk LA
Ginekol Pol; 2015 Apr; 86(4):300-4. PubMed ID: 26117990
[TBL] [Abstract][Full Text] [Related]
4. Adipose tissue dysfunction in polycystic ovary syndrome.
Villa J; Pratley RE
Curr Diab Rep; 2011 Jun; 11(3):179-84. PubMed ID: 21424395
[TBL] [Abstract][Full Text] [Related]
5. Adipose tissue, metabolic syndrome and polycystic ovary syndrome: from pathophysiology to treatment.
Garruti G; Depalo R; Vita MG; Lorusso F; Giampetruzzi F; Damato AB; Giorgino F
Reprod Biomed Online; 2009 Oct; 19(4):552-63. PubMed ID: 19909598
[TBL] [Abstract][Full Text] [Related]
6. Metabolic Syndrome in Polycystic Ovary Syndrome.
Pasquali R
Front Horm Res; 2018; 49():114-130. PubMed ID: 29894990
[TBL] [Abstract][Full Text] [Related]
7. Polycystic ovary syndrome: reviewing diagnosis and management of metabolic disturbances.
Spritzer PM
Arq Bras Endocrinol Metabol; 2014 Mar; 58(2):182-7. PubMed ID: 24830595
[TBL] [Abstract][Full Text] [Related]
8. Adipose insulin resistance is associated with cardiovascular risk factors in polycystic ovary syndrome.
Mu L; Li R; Lai Y; Zhao Y; Qiao J
J Endocrinol Invest; 2019 May; 42(5):541-548. PubMed ID: 30206805
[TBL] [Abstract][Full Text] [Related]
9. Polycystic Ovary Syndrome as a Proinflammatory State: The Role of Adipokines.
Dimitriadis GK; Kyrou I; Randeva HS
Curr Pharm Des; 2016; 22(36):5535-5546. PubMed ID: 27464726
[TBL] [Abstract][Full Text] [Related]
10. Peri-muscular adipose tissue may play a unique role in determining insulin sensitivity/resistance in women with polycystic ovary syndrome.
Morrison SA; Goss AM; Azziz R; Raju DA; Gower BA
Hum Reprod; 2017 Jan; 32(1):185-192. PubMed ID: 27827322
[TBL] [Abstract][Full Text] [Related]
11. Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges.
Jeanes YM; Reeves S
Nutr Res Rev; 2017 Jun; 30(1):97-105. PubMed ID: 28222828
[TBL] [Abstract][Full Text] [Related]
12. Endocrine and metabolic characteristics in polycystic ovary syndrome.
Glintborg D
Dan Med J; 2016 Apr; 63(4):. PubMed ID: 27034186
[TBL] [Abstract][Full Text] [Related]
13. Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies.
Sanchez-Garrido MA; Tena-Sempere M
Mol Metab; 2020 May; 35():100937. PubMed ID: 32244180
[TBL] [Abstract][Full Text] [Related]
14. Chronic Low Grade Inflammation in Pathogenesis of PCOS.
Rudnicka E; Suchta K; Grymowicz M; Calik-Ksepka A; Smolarczyk K; Duszewska AM; Smolarczyk R; Meczekalski B
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33917519
[TBL] [Abstract][Full Text] [Related]
15. Adipocyte and steroidogenic cell cross-talk in polycystic ovary syndrome.
de Medeiros SF; Rodgers RJ; Norman RJ
Hum Reprod Update; 2021 Jun; 27(4):771-796. PubMed ID: 33764457
[TBL] [Abstract][Full Text] [Related]
16. Metabolic syndrome and cardiometabolic risk in PCOS.
Cussons AJ; Stuckey BG; Watts GF
Curr Diab Rep; 2007 Feb; 7(1):66-73. PubMed ID: 17254520
[TBL] [Abstract][Full Text] [Related]
17. Changes in the PCOS phenotype with age.
Hsu MI
Steroids; 2013 Aug; 78(8):761-6. PubMed ID: 23624031
[TBL] [Abstract][Full Text] [Related]
18. Polycystic ovary syndrome and metabolic syndrome.
Ali AT
Ceska Gynekol; 2015 Aug; 80(4):279-89. PubMed ID: 26265416
[TBL] [Abstract][Full Text] [Related]
19. Cardiometabolic Risk in PCOS: More than a Reproductive Disorder.
Torchen LC
Curr Diab Rep; 2017 Nov; 17(12):137. PubMed ID: 29128916
[TBL] [Abstract][Full Text] [Related]
20. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models.
Caldwell AS; Middleton LJ; Jimenez M; Desai R; McMahon AC; Allan CM; Handelsman DJ; Walters KA
Endocrinology; 2014 Aug; 155(8):3146-59. PubMed ID: 24877633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]